appears in the following:
Wednesday, November 30, 2022
More than 3.5 million infusions of antibodies have been used to treat COVID. The treatment is being phased out because the antibodies have lost their efficacy against new variants of coronavirus.
Monday, November 28, 2022
The disease formerly known as monkeypox has a new name: "mpox." It's not much of a depature, but it's less stigmatizing, according to advocates who have been calling for a change of name.
Sunday, November 20, 2022
The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
Tuesday, November 08, 2022
For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
Thursday, November 03, 2022
The updated recommendations seek to course correct after guidelines from 2016 were criticized for harshly limiting access to needed pain medication.
Wednesday, October 19, 2022
About half of U.S. adults get their flu shot each year, but a new report finds that Black, Hispanic and Native Americans are less likely to get a flu vaccine — and more likely to be hospitalized.
Monday, October 17, 2022
Early fears of an escalating outbreak have not come to pass. Scientists are finding that the virus needs a very particular set of circumstances to spread effectively.
Tuesday, October 11, 2022
New daily monkeypox cases have been falling, and the CDC says cases are probably going to plateau or decline over the next few weeks.
Thursday, September 15, 2022
In the first congressional hearing on monkeypox, federal officials were criticized for being slow to act, and struggling to apply the lessons of the pandemic to the current outbreak.
Wednesday, September 14, 2022
Congress held its hearing on the federal response to the monkeypox outbreak. That comes as cases — and vaccinations — slow down in the U.S.
Monday, September 12, 2022
Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done.
Friday, September 09, 2022
A new report from the Centers for Disease Control and Prevention finds that a disproportionate number of people who are contracting monkeypox in the U.S. are also HIV-positive.
Friday, August 26, 2022
Rates of new cases are declining in major cities, suggesting public health campaigns are working.
Thursday, August 25, 2022
All summer, NPR's Science Desk has been looking at sweat. Humans are covered with millions of sweat glands, but it wasn't always that way. When did humans start to sweat?
Monday, August 22, 2022
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
Friday, August 19, 2022
Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.
Thursday, August 18, 2022
The U.S. is facing a shortage of the monkeypox vaccine as the outbreak grows rapidly. The White House is pursuing a controversial strategy where each person only gets a fraction of the full dose.
Friday, August 12, 2022
The CDC stopped recommending quarantines or test-to-stay in schools. It's part of a relaxation of COVID guidance that acknowledges the virus is here to stay, and that many people have prior immunity.
Thursday, August 11, 2022
Revised guidance from the Centers for Disease Control and Prevention looks to minimize COVID-19's disruption of daily life while conceding that the pandemic isn't over.
Tuesday, August 09, 2022
The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.